Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells

Rosamaria Lappano, Camillo Rosano, Paola De Marco, Ernestina Marianna De Francesco, Vincenzo Pezzi, Marcello Maggiolini

Research output: Contribution to journalArticle

Abstract

Estrogens are structurally related steroids that regulate important physiological processes. 17β-estradiol (E2) is reversibly oxidized to estrone (E1) and both E2 and E1 can be irreversibly converted to estriol (E3), which also originates directly from androstenedione. The action of E2 has been traditionally explained by the binding to the estrogen receptor (ER) α and ERβ, however the G protein-coupled receptor (GPR) 30 has been recently involved in the rapid signaling triggered by estrogens. Although the role of E2 in the development of breast cancer has been largely documented, the contribution of E3 still remains to be completely evaluated. Here, we demonstrate for the first time that E3 acts as a GPR30 antagonist since it was able to inhibit the GPR30-mediated responses such as the rapid ERK activation, the up-regulation of target genes like c-fos and connective tissue growth factor, the proliferative effects observed in ER-negative SkBr3 cells.

Original languageEnglish
Pages (from-to)162-170
Number of pages9
JournalMolecular and Cellular Endocrinology
Volume320
Issue number1-2
DOIs
Publication statusPublished - May 2010

Fingerprint

Estriol
Estrogen Receptors
Cells
Breast Neoplasms
Estrogens
Physiological Phenomena
Connective Tissue Growth Factor
fos Genes
Androstenedione
Estrone
G-Protein-Coupled Receptors
Estradiol
Up-Regulation
Genes
Chemical activation
Steroids
Estrogen Receptor Antagonists

Keywords

  • Breast cancer cells
  • Estriol
  • Estrogen receptor
  • Estrogen signaling
  • GPR30

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Biochemistry

Cite this

Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. / Lappano, Rosamaria; Rosano, Camillo; De Marco, Paola; De Francesco, Ernestina Marianna; Pezzi, Vincenzo; Maggiolini, Marcello.

In: Molecular and Cellular Endocrinology, Vol. 320, No. 1-2, 05.2010, p. 162-170.

Research output: Contribution to journalArticle

Lappano, Rosamaria ; Rosano, Camillo ; De Marco, Paola ; De Francesco, Ernestina Marianna ; Pezzi, Vincenzo ; Maggiolini, Marcello. / Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. In: Molecular and Cellular Endocrinology. 2010 ; Vol. 320, No. 1-2. pp. 162-170.
@article{810ae1c1ccbc4da0aa0508a976c41c56,
title = "Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells",
abstract = "Estrogens are structurally related steroids that regulate important physiological processes. 17β-estradiol (E2) is reversibly oxidized to estrone (E1) and both E2 and E1 can be irreversibly converted to estriol (E3), which also originates directly from androstenedione. The action of E2 has been traditionally explained by the binding to the estrogen receptor (ER) α and ERβ, however the G protein-coupled receptor (GPR) 30 has been recently involved in the rapid signaling triggered by estrogens. Although the role of E2 in the development of breast cancer has been largely documented, the contribution of E3 still remains to be completely evaluated. Here, we demonstrate for the first time that E3 acts as a GPR30 antagonist since it was able to inhibit the GPR30-mediated responses such as the rapid ERK activation, the up-regulation of target genes like c-fos and connective tissue growth factor, the proliferative effects observed in ER-negative SkBr3 cells.",
keywords = "Breast cancer cells, Estriol, Estrogen receptor, Estrogen signaling, GPR30",
author = "Rosamaria Lappano and Camillo Rosano and {De Marco}, Paola and {De Francesco}, {Ernestina Marianna} and Vincenzo Pezzi and Marcello Maggiolini",
year = "2010",
month = "5",
doi = "10.1016/j.mce.2010.02.006",
language = "English",
volume = "320",
pages = "162--170",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells

AU - Lappano, Rosamaria

AU - Rosano, Camillo

AU - De Marco, Paola

AU - De Francesco, Ernestina Marianna

AU - Pezzi, Vincenzo

AU - Maggiolini, Marcello

PY - 2010/5

Y1 - 2010/5

N2 - Estrogens are structurally related steroids that regulate important physiological processes. 17β-estradiol (E2) is reversibly oxidized to estrone (E1) and both E2 and E1 can be irreversibly converted to estriol (E3), which also originates directly from androstenedione. The action of E2 has been traditionally explained by the binding to the estrogen receptor (ER) α and ERβ, however the G protein-coupled receptor (GPR) 30 has been recently involved in the rapid signaling triggered by estrogens. Although the role of E2 in the development of breast cancer has been largely documented, the contribution of E3 still remains to be completely evaluated. Here, we demonstrate for the first time that E3 acts as a GPR30 antagonist since it was able to inhibit the GPR30-mediated responses such as the rapid ERK activation, the up-regulation of target genes like c-fos and connective tissue growth factor, the proliferative effects observed in ER-negative SkBr3 cells.

AB - Estrogens are structurally related steroids that regulate important physiological processes. 17β-estradiol (E2) is reversibly oxidized to estrone (E1) and both E2 and E1 can be irreversibly converted to estriol (E3), which also originates directly from androstenedione. The action of E2 has been traditionally explained by the binding to the estrogen receptor (ER) α and ERβ, however the G protein-coupled receptor (GPR) 30 has been recently involved in the rapid signaling triggered by estrogens. Although the role of E2 in the development of breast cancer has been largely documented, the contribution of E3 still remains to be completely evaluated. Here, we demonstrate for the first time that E3 acts as a GPR30 antagonist since it was able to inhibit the GPR30-mediated responses such as the rapid ERK activation, the up-regulation of target genes like c-fos and connective tissue growth factor, the proliferative effects observed in ER-negative SkBr3 cells.

KW - Breast cancer cells

KW - Estriol

KW - Estrogen receptor

KW - Estrogen signaling

KW - GPR30

UR - http://www.scopus.com/inward/record.url?scp=77949568658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949568658&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2010.02.006

DO - 10.1016/j.mce.2010.02.006

M3 - Article

C2 - 20138962

AN - SCOPUS:77949568658

VL - 320

SP - 162

EP - 170

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -